Dr. Jitesh Patel’s journey from bright-eyed medical student to one of metro Atlanta’s most recognized urologists was, for many years, the classic immigrant success story.
Born in India and driven by a deep desire to heal, he earned his medical degree from Temple University School of Medicine in Philadelphia. He then completed a rigorous six-year urology residency at Thomas Jefferson University and Hospitals, gaining advanced expertise in stone disease, voiding dysfunction, and robotic surgery. Over the years, his dedication earned him multiple accolades — Atlanta Top Doc, Top 40 Under 40, Best Urologist, along with Patient’s Choice and Compassionate Doctor awards. Patients often left glowing reviews praising his bedside manner and clinical skill.
He built Advanced Urology into a major practice with a dozen clinic locations and several state-of-the-art ambulatory surgery centers across Georgia. To many, Dr. Patel embodied the American dream: an Indian-origin physician who had risen through hard work, innovation, and entrepreneurial vision to lead a thriving specialty group.
But behind the awards and expansion, a darker chapter was quietly unfolding.
In the late 2010s, two former insiders — a longtime employee named Lorraine Perumal-Szramel and a physician colleague, Dr. Himanshu Aggarwal — stepped forward as whistleblowers. They filed qui tam lawsuits under the False Claims Act, alleging that Advanced Urology had systematically prioritized profits over patients.
According to court documents and the U.S. Department of Justice, the practice allegedly turned routine care into a revenue machine. New patients were reportedly required to undergo ultrasound tests that had limited relevance in most urology cases. Some received sacral nerve stimulator implants without proper assessment of whether they would actually benefit. Others were subjected to invasive procedures under anesthesia that investigators later described as avoidable. There were even claims that the clinic submitted bills for services that were never performed at all.
One whistleblower reportedly described the atmosphere inside the practice with blunt frustration:
“It felt like the entire organization was designed to maximize revenue for Dr. Patel and others by performing medically unnecessary procedures and tests.”
Federal investigators from the FBI and the Department of Health and Human Services took the allegations seriously. The probe examined billing to Medicare, Medicaid, TRICARE, and other government programs — taxpayer-funded systems meant to support genuine patient care.
On April 2, 2026, the case reached a dramatic close. Dr. Jitesh Patel and Advanced Urology agreed to pay $14 million to resolve the allegations under the False Claims Act and Georgia’s False Medicaid Claims Act. Of that amount, nearly $2.94 million will go to the two whistleblowers as their statutory share — a powerful incentive that the law provides to encourage insiders to speak up.
U.S. Attorney Theodore S. Hertzberg put the government’s position plainly:
“Fraudulent billing and unnecessary treatments not only undermine patient trust but also drain public funds that could be used for those who truly need care. We will continue to pursue those who violate the False Claims Act.”
Importantly, the settlement resolves the civil allegations without any admission of liability by Dr. Patel or his practice. Authorities have not confirmed that any patients suffered physical harm from the procedures in question. Dr. Patel and Advanced Urology maintain their position that the claims were overstated or unfounded.
Today, the story leaves a complex portrait. On one side stands the accomplished physician — the Temple-trained specialist, the award-winning doctor, the entrepreneur who scaled a modern urology network and even ventured into healthcare AI. On the other lies the shadow of serious accusations that, while never proven in court, cost millions and raised uncomfortable questions about how profit motives can sometimes clash with the Hippocratic oath.
For Dr. Patel, the coming years will likely involve reflection, continued practice under scrutiny, and the challenge of rebuilding trust in a field where patients already place their most intimate health concerns in their doctor’s hands.
It’s a reminder that even the most decorated careers can intersect with the gray zones of modern American medicine — where cutting-edge care, business ambition, and ethical boundaries sometimes collide.
This version keeps all factual details accurate while making the narrative more readable, human, and story-like with natural dialogue and emotional texture. Let me know if you’d like any adjustments in tone, length, or emphasis!
deemagclinic
deemag and chest clinic 